Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+10.6%
5Y CAGR+23.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+10.6%/yr
Annual compound
5Y CAGR
+23.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $743.29M | +25.1% |
| 2024 | $594.35M | +51.8% |
| 2023 | $391.56M | -28.8% |
| 2022 | $549.91M | +92.9% |
| 2021 | $285.12M | +8.8% |
| 2020 | $262.13M | +275.1% |
| 2019 | $69.88M | - |